Stock-based Compensation (Details Narrative) $ in Thousands |
9 Months Ended |
|---|---|
|
Sep. 30, 2025
USD ($)
shares
| |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Term of the award | The term of the 2013 Plan was for 10 years |
| Unrecognized share based compensation | $ | $ 990 |
| Unrecognized share based compensation, recognition period | 1 year 8 months 12 days |
| 2013 Equity Compensation Plan [Member] | |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Stock awards including restricted stock options grants awards issued and exercised | 434,334 |
| 2025 Equity Compensation Plan [Member] | |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Stock awards including restricted stock options grants awards issued and exercised | 116,500 |
| Stock awards available for grant | 646,548 |
| X | ||||||||||
- Definition Stock awards available for grant. No definition available.
|
| X | ||||||||||
- Definition Stock awards including restricted stock grants and option grants issued and exercised. No definition available.
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Description of terms of award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|